A comprehensive view of Obesity. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global soft tissue repair market expected to grow to US$17.2B by 2027, with CAGR growth of 4.7% from 2022 to 2027; growth driven by increases in obesity, cardiovascular diseases, trauma, growing need to manage patient blood loss, increasing R&D in field

FDA approves Rhythm Pharmaceuticals’ Imcivree setmelanotide injectable to treat obesity in patients with Bardet-Biedl syndrome; FDA did not approve drug for patients with Alstroem syndrome

Allurion Technologies launches clinical trial NCT05368259 to study effectiveness, safety of Allurion Gastric Balloon System and moderate intensity lifestyle to promote weight loss; AGBS involves placement of up to two balloons in one-year period

FDA approves Eli Lilly’s injectable Mounjaro tirzepatide type 2 diabetes drug that lowers blood sugar, helps patients lose weight; Mounjaro sales projected to reach up to US$14B annually by 2030

FDA approves Ilya Pharma’s IND for ILP100-Topical immunotherapy surgical wound treatment for patients with prediabetes, diabetes, obesity; company accelerating plans for Phase 2 study, with patients in study having increased risk of wound complications

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count